Eversept Partners, LP Amneal Pharmaceuticals, Inc. Transaction History

Eversept Partners, LP

$1.26 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$2.76 - $4.59 $7.23 Million - $12 Million	-2,620,263 Reduced 49.77%	2,644,988 $11.2 Million
Q2 2023 Nov 08, 2023	BUY	$1.33 - $3.1 $109,332 - $254,835	82,205 Added 1.59%	5,265,251 $16.3 Million
Q2 2023 Aug 14, 2023	BUY	$1.33 - $3.1 $109,332 - $254,835	82,205 Added 1.59%	5,265,251 $16.3 Million
Q1 2023 Nov 08, 2023	BUY	$1.27 - $2.7 $5.53 Million - $11.8 Million	4,352,086 Added 523.74%	5,183,046 $7.2 Million
Q1 2023 May 15, 2023	BUY	$1.27 - $2.7 $5.53 Million - $11.8 Million	4,352,086 Added 523.74%	5,183,046 $7.2 Million
Q4 2022 Nov 08, 2023	SELL	$1.96 - $2.61 $7.57 Million - $10.1 Million	-3,859,852 Reduced 82.29%	830,960 $1.65 Million
Q4 2022 Feb 14, 2023	SELL	$1.96 - $2.61 $7.57 Million - $10.1 Million	-3,859,852 Reduced 82.29%	830,960 $1.65 Million
Q3 2022 Nov 08, 2023	SELL	$2.02 - $3.62 $1.62 Million - $2.91 Million	-803,468 Reduced 14.62%	4,690,812 $9.48 Million
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.62 $1.62 Million - $2.91 Million	-803,468 Reduced 14.62%	4,690,812 $9.48 Million
Q2 2022 Nov 08, 2023	BUY	$3.01 - $4.46 $8,376 - $12,412	2,783 Added 0.05%	5,494,280 $17.5 Million
Q2 2022 Aug 15, 2022	BUY	$3.01 - $4.46 $8,376 - $12,412	2,783 Added 0.05%	5,494,280 $17.5 Million
Q1 2022 Nov 08, 2023	BUY	$3.9 - $4.89 $882,359 - $1.11 Million	226,246 Added 4.3%	5,491,497 $22.9 Million
Q1 2022 May 16, 2022	SELL	$3.9 - $4.89 $3.7 Million - $4.64 Million	-949,075 Reduced 14.74%	5,491,497 $22.9 Million
Q4 2021 Nov 08, 2023	SELL	$3.95 - $5.85 $1.62 Million - $2.39 Million	-409,262 Reduced 5.97%	6,440,572 $30.9 Million
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $1.62 Million - $2.39 Million	-409,262 Reduced 5.97%	6,440,572 $30.9 Million
Q3 2021 Nov 08, 2023	BUY	$4.31 - $5.64 $5.28 Million - $6.91 Million	1,225,109 Added 21.78%	6,849,834 $36.6 Million
Q3 2021 Nov 15, 2021	BUY	$4.31 - $5.64 $5.28 Million - $6.91 Million	1,225,109 Added 21.78%	6,849,834 $36.6 Million
Q2 2021 Nov 08, 2023	BUY	$5.12 - $6.82 $4.45 Million - $5.93 Million	869,245 Added 18.28%	5,624,725 $28.8 Million
Q2 2021 Aug 16, 2021	BUY	$5.12 - $6.82 $4.45 Million - $5.93 Million	869,245 Added 18.28%	5,624,725 $28.8 Million
Q1 2021 Nov 08, 2023	BUY	$4.74 - $7.38 $17 Million - $26.4 Million	3,577,327 Added 303.64%	4,755,480 $32 Million
Q1 2021 May 13, 2021	BUY	$4.74 - $7.38 $17 Million - $26.4 Million	3,577,327 Added 303.64%	4,755,480 $32 Million
Q4 2020 Nov 08, 2023	SELL	$3.95 - $5.42 $16.1 Million - $22.2 Million	-4,087,098 Reduced 77.62%	1,178,153 $5.38 Million
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $5.84 Million - $8.01 Million	-1,478,055 Reduced 55.65%	1,178,153 $5.38 Million
Q3 2020 Nov 08, 2023	BUY	$3.54 - $5.27 $6.26 Million - $9.33 Million	1,769,621 Added 199.6%	2,656,208 $10.3 Million
Q3 2020 Nov 13, 2020	BUY	$3.54 - $5.27 $6.26 Million - $9.33 Million	1,769,621 Added 199.6%	2,656,208 $10.3 Million
Q2 2020 Nov 08, 2023	SELL	$2.87 - $5.46 $12.6 Million - $23.9 Million	-4,378,664 Reduced 83.16%	886,587 $4.22 Million
Q2 2020 Aug 13, 2020	BUY	$2.87 - $5.46 $2.54 Million - $4.84 Million	886,587 New	886,587 $4.22 Million

Others Institutions Holding AMRX

# of Institutions

185

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.26B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Account